-+ 0.00%
-+ 0.00%
-+ 0.00%

Eton Pharmaceuticals Q1 Adj. EPS $0.07 Beats $0.05 Estimate, Sales $17.28M Beat $15.13M Estimate

Benzinga·05/13/2025 20:05:31
Listen to the news
Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.05 by 40 percent. The company reported quarterly sales of $17.28 million which beat the analyst consensus estimate of $15.13 million by 14.22 percent. This is a 116.95 percent increase over sales of $7.97 million the same period last year.